In the latest trading session, 0.52 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 2.02. With the company’s most recent per share price at $8.85 changed hands at -$0.11 or -1.23% at last look, the market valuation stands at $1.02B. APLT’s current price is a discount, trading about -6.1% off its 52-week high of $9.39. The share price had its 52-week low at $1.79, which suggests the last value was 79.77% up since then. When we look at Applied Therapeutics Inc’s average trading volume, we note the 10-day average is 1.53 million shares, with the 3-month average coming to 2.45 million.
Analysts gave the Applied Therapeutics Inc (APLT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APLT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Applied Therapeutics Inc’s EPS for the current quarter is expected to be -0.16.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT was in red as seen in intraday trades today. With action -0.45%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 164.18%, with the 5-day performance at -0.45% in the red. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is 14.94% up. Looking at the short shares, we see there were 12.36 million shares sold at short interest cover period of 2.57 days.
Applied Therapeutics Inc (APLT) estimates and forecasts
Data shows that the Applied Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 100.68% over the past 6 months, a 40.85% in annual growth rate that is considerably higher than the industry average of 17.20%. Year-over-year growth is forecast to reach -83.00% down from the last financial year.
4 analysts are of the opinion that Applied Therapeutics Inc’s revenue for the current quarter will be 750k. The estimates for the next quarter sales put growth at -212.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.72%. The 2024 estimates are for Applied Therapeutics Inc earnings to increase by 29.48%.
APLT Dividends
Applied Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-07.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.31% of Applied Therapeutics Inc shares while 95.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 100.88%. There are 95.53% institutions holding the Applied Therapeutics Inc stock share, with FRANKLIN RESOURCES INC the top institutional holder. As of 2024-06-30, the company held 8.1496% of the shares, roughly 10.21 million APLT shares worth $47.69 million.
VR ADVISER, LLC holds the second largest percentage of outstanding shares, with 7.6149% or 9.54 million shares worth $44.57 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jul 31, 2024 were Franklin Strategic Series-Franklin Biotechnology Discove and Vanguard Total Stock Market Index Fund. With 3.45 shares estimated at $30.19 million under it, the former controlled 3.00% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.75% of the shares, roughly 3.15 shares worth around $27.6 million.
